Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
2.593
-0.057 (-2.15%)
Nov 21, 2024, 4:00 PM EST - Market closed
Arcadia Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 3.94 | 6.52 | 20.64 | 28.69 | 14.04 | 8.42 | Upgrade
|
Short-Term Investments | 2.64 | 5.12 | - | - | 11.63 | 16.92 | Upgrade
|
Cash & Short-Term Investments | 6.58 | 11.64 | 20.64 | 28.69 | 25.67 | 25.33 | Upgrade
|
Cash Growth | -58.11% | -43.61% | -28.03% | 11.76% | 1.32% | 16.08% | Upgrade
|
Accounts Receivable | 0.88 | 0.51 | 1.22 | 1.37 | 1.41 | 0.6 | Upgrade
|
Receivables | 2.71 | 0.51 | 1.22 | 1.37 | 1.41 | 0.6 | Upgrade
|
Inventory | 0.84 | 1.96 | 2.32 | 4.43 | 3.81 | 1.79 | Upgrade
|
Prepaid Expenses | 0.52 | 0.81 | 0.8 | 0.9 | 0.81 | 0.71 | Upgrade
|
Other Current Assets | 0.07 | 0.05 | 0.42 | - | - | - | Upgrade
|
Total Current Assets | 10.71 | 14.97 | 25.4 | 35.39 | 31.7 | 28.44 | Upgrade
|
Property, Plant & Equipment | 0.36 | 1.18 | 2.53 | 5.37 | 9.37 | 3.76 | Upgrade
|
Goodwill | - | - | - | - | 0.41 | - | Upgrade
|
Other Intangible Assets | 0.04 | 0.04 | 0.04 | 0.48 | 0.37 | - | Upgrade
|
Other Long-Term Assets | 0.16 | 3.52 | 0.96 | 2.67 | 5.51 | 0.37 | Upgrade
|
Total Assets | 15.24 | 19.71 | 28.92 | 43.92 | 47.35 | 32.57 | Upgrade
|
Accounts Payable | 1.69 | 0.8 | 0.91 | 1.41 | 0.73 | 0.49 | Upgrade
|
Accrued Expenses | 0.03 | 1.58 | 1.56 | 2 | 2.18 | 2.72 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 1.14 | 0.02 | Upgrade
|
Current Portion of Leases | 0.35 | 0.85 | 1.01 | 1.07 | 0.72 | 0.61 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 0.01 | 0.04 | Upgrade
|
Other Current Liabilities | 0.26 | 0.35 | 0.73 | 0.56 | 1.54 | 1.82 | Upgrade
|
Total Current Liabilities | 2.33 | 3.59 | 4.21 | 5.04 | 6.31 | 5.71 | Upgrade
|
Long-Term Debt | - | - | - | - | 2.11 | 0.11 | Upgrade
|
Long-Term Leases | - | 0.16 | 1.01 | 2.22 | 5.39 | 1.5 | Upgrade
|
Other Long-Term Liabilities | 2.76 | 3.26 | 2.81 | 5.46 | 4.99 | 16.94 | Upgrade
|
Total Liabilities | 5.09 | 7 | 8.02 | 12.72 | 18.8 | 24.25 | Upgrade
|
Common Stock | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | Upgrade
|
Additional Paid-In Capital | 284.92 | 284.52 | 278.83 | 257.52 | 239.5 | 214.83 | Upgrade
|
Retained Earnings | -274.81 | -271.84 | -257.86 | -226.49 | -211.83 | -207.17 | Upgrade
|
Comprehensive Income & Other | 0.12 | 0.1 | - | - | - | 0 | Upgrade
|
Total Common Equity | 10.29 | 12.84 | 21.03 | 31.09 | 27.73 | 7.71 | Upgrade
|
Minority Interest | -0.14 | -0.14 | -0.13 | 0.1 | 0.83 | 0.62 | Upgrade
|
Shareholders' Equity | 10.15 | 12.7 | 20.9 | 31.2 | 28.55 | 8.33 | Upgrade
|
Total Liabilities & Equity | 15.24 | 19.71 | 28.92 | 43.92 | 47.35 | 32.57 | Upgrade
|
Total Debt | 0.35 | 1.01 | 2.02 | 3.29 | 9.35 | 2.24 | Upgrade
|
Net Cash (Debt) | 6.23 | 10.64 | 18.63 | 25.39 | 16.32 | 23.09 | Upgrade
|
Net Cash Growth | -56.82% | -42.91% | -26.64% | 55.63% | -29.35% | 5.82% | Upgrade
|
Net Cash Per Share | 4.57 | 8.60 | 31.08 | 47.73 | 65.53 | 145.17 | Upgrade
|
Filing Date Shares Outstanding | 1.36 | 1.36 | 0.86 | 0.55 | 0.53 | 0.22 | Upgrade
|
Total Common Shares Outstanding | 1.36 | 1.29 | 0.62 | 0.55 | 0.34 | 0.22 | Upgrade
|
Working Capital | 8.38 | 11.38 | 21.19 | 30.35 | 25.38 | 22.73 | Upgrade
|
Book Value Per Share | 7.54 | 9.99 | 34.14 | 56.06 | 82.45 | 35.65 | Upgrade
|
Tangible Book Value | 10.25 | 12.8 | 20.99 | 30.61 | 26.95 | 7.71 | Upgrade
|
Tangible Book Value Per Share | 7.51 | 9.96 | 34.08 | 55.19 | 80.13 | 35.65 | Upgrade
|
Machinery | - | 0.95 | 1.52 | 5.1 | 5.61 | 3.92 | Upgrade
|
Leasehold Improvements | - | 1.59 | 1.59 | 2.31 | 2.23 | 2.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.